OMALIZUMAB-IGEC

OMALIZUMAB-IGEC was reported 89 times

OMALIZUMAB-IGEC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URETHRAL NEOPLASM 1 0.0227
1 TOOTH RESTORATION 2 0.0189
2 ADMINISTRATION SITE PRURITUS 1 0.0078
3 NASAL OEDEMA 9 0.0050
4 INJECTION SITE PLAQUE 1 0.0048
5 URTICARIA CHRONIC 2 0.0036
6 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
7 HARVEY-BRADSHAW INDEX INCREASED 1 0.0034
8 ENLARGED UVULA 1 0.0022
9 SUSPECTED OFF LABEL USE 10 0.0022
10 EHLERS-DANLOS SYNDROME 1 0.0022
11 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
12 URTICARIAL VASCULITIS 1 0.0019
13 OVERLAP SYNDROME 1 0.0014
14 BORDERLINE PERSONALITY DISORDER 1 0.0014
15 CYCLIC VOMITING SYNDROME 1 0.0014
16 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
17 PUPILLARY REFLEX IMPAIRED 2 0.0011
18 CONJUNCTIVAL OEDEMA 1 0.0010
19 MAST CELL ACTIVATION SYNDROME 1 0.0007
20 INJECTION RELATED REACTION 1 0.0006
21 BLADDER NEOPLASM 1 0.0006
22 BODY TEMPERATURE ABNORMAL 1 0.0005
23 CALCINOSIS 1 0.0004
24 SINUS PAIN 1 0.0004
25 HAEMORRHAGE URINARY TRACT 1 0.0004
26 RESPIRATORY TRACT INFECTION 10 0.0004
27 EXFOLIATIVE RASH 1 0.0004
28 ANGIOEDEMA 16 0.0004
29 INJECTION SITE HYPERSENSITIVITY 1 0.0003
30 PHARYNGEAL SWELLING 3 0.0003
31 CONJUNCTIVAL HYPERAEMIA 1 0.0003
32 ASTHMATIC CRISIS 1 0.0003
33 ANAPHYLACTOID REACTION 1 0.0002
34 PRODUCT SUBSTITUTION ISSUE 13 0.0002
35 IRON DEFICIENCY 1 0.0002
36 LOCALISED OEDEMA 1 0.0002
37 WHEEZING 12 0.0002
38 INJECTION SITE INFLAMMATION 1 0.0002
39 DERMATITIS EXFOLIATIVE 1 0.0002
40 HYPOAESTHESIA ORAL 3 0.0002
41 POLYARTHRITIS 1 0.0002
42 EXERCISE TOLERANCE DECREASED 1 0.0002
43 ODYNOPHAGIA 1 0.0002
44 SYMPTOM RECURRENCE 1 0.0002
45 OEDEMA 9 0.0002
46 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
47 PHARYNGITIS 2 0.0002
48 THERAPEUTIC RESPONSE CHANGED 1 0.0002
49 MYDRIASIS 2 0.0002
50 SKIN MASS 1 0.0001
51 CARPAL TUNNEL SYNDROME 2 0.0001
52 PRODUCT SUPPLY ISSUE 1 0.0001
53 SENSITIVE SKIN 1 0.0001
54 SUNBURN 1 0.0001
55 CONCUSSION 1 0.0001
56 RHINITIS 1 0.0001
57 ASTHMA 14 0.0001
58 HAIR DISORDER 1 0.0001
59 URTICARIA 20 0.0001
60 FACE OEDEMA 2 0.0001
61 SKIN PLAQUE 1 0.0001
62 INTENTIONAL DOSE OMISSION 3 0.0001
63 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
64 OVARIAN CYST 1 0.0001
65 SCRATCH 1 0.0001
66 HEREDITARY ANGIOEDEMA 1 0.0001
67 IMPAIRED DRIVING ABILITY 1 0.0001
68 EYELID OEDEMA 1 0.0001
69 BLOOD IRON DECREASED 1 0.0001
70 PRESYNCOPE 2 0.0001
71 ANAPHYLACTIC REACTION 4 0.0001
72 BRONCHOSPASM 1 0.0001
73 PARAESTHESIA ORAL 1 0.0001
74 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
75 PHARYNGEAL OEDEMA 1 0.0001
76 PHOTOSENSITIVITY REACTION 1 0.0001
77 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
78 LIP SWELLING 2 0.0001
79 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
80 BURNING SENSATION 4 0.0001
81 PELVIC PAIN 1 0.0001
82 CHEST PAIN 10 0.0001
83 CONJUNCTIVITIS 1 0.0001
84 MIDDLE INSOMNIA 1 0.0001
85 SLEEP APNOEA SYNDROME 1 0.0001
86 CHOKING 1 0.0001
87 ORAL HERPES 1 0.0001
88 BLINDNESS 2 0.0000
89 KNEE ARTHROPLASTY 1 0.0000
90 MOUTH ULCERATION 1 0.0000
91 RETCHING 1 0.0000
92 RECTAL HAEMORRHAGE 2 0.0000
93 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
94 SWELLING FACE 3 0.0000
95 RASH MACULO-PAPULAR 1 0.0000
96 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
97 PRODUCT AVAILABILITY ISSUE 1 0.0000
98 TINNITUS 2 0.0000
99 COUGH 12 0.0000
100 PALPITATIONS 5 0.0000
101 PRURITUS 16 0.0000
102 HEPATITIS 1 0.0000
103 CHEST DISCOMFORT 4 0.0000
104 ANAPHYLACTIC SHOCK 1 0.0000
105 INFLAMMATION 2 0.0000
106 UNRESPONSIVE TO STIMULI 1 0.0000
107 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
108 PNEUMONIA 12 0.0000
109 THROAT TIGHTNESS 1 0.0000
110 PALLOR 1 0.0000
111 SKIN LESION 1 0.0000
112 INFLUENZA LIKE ILLNESS 3 0.0000
113 ANGINA PECTORIS 1 0.0000
114 MALAISE 15 0.0000
115 DYSPHONIA 2 0.0000
116 RESPIRATORY DISORDER 1 0.0000
117 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
118 SWOLLEN TONGUE 1 0.0000
119 MIGRAINE 3 0.0000
120 HIP FRACTURE 1 0.0000
121 EYE PRURITUS 1 0.0000
122 ERYTHEMA 6 0.0000
123 RASH MACULAR 1 0.0000
124 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
125 VOMITING 13 0.0000
126 EPISTAXIS 2 0.0000
127 HALLUCINATION 2 0.0000
128 DYSPNOEA 15 0.0000
129 ARTHRALGIA 10 0.0000
130 ROAD TRAFFIC ACCIDENT 1 0.0000
131 SKIN EXFOLIATION 2 0.0000
132 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
133 THROAT IRRITATION 1 0.0000
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
135 SUICIDAL IDEATION 2 0.0000
136 NEPHROLITHIASIS 1 0.0000
137 HYPOKALAEMIA 1 0.0000
138 OROPHARYNGEAL PAIN 2 0.0000
139 SWELLING 2 0.0000
140 DISEASE RECURRENCE 1 0.0000
141 RASH ERYTHEMATOUS 1 0.0000
142 CONTUSION 2 0.0000
143 DIZZINESS 10 0.0000
144 CONDITION AGGRAVATED 6 0.0000
145 FLUID RETENTION 1 0.0000
146 ILLNESS 2 0.0000
147 HEADACHE 12 0.0000
148 ECZEMA 1 0.0000
149 SPEECH DISORDER 1 0.0000
150 ASTHENIA 7 0.0000
151 MYALGIA 3 0.0000
152 URINARY TRACT INFECTION 3 0.0000
153 HERPES ZOSTER 1 0.0000
154 LETHARGY 1 0.0000
155 EYE IRRITATION 1 0.0000
156 NASOPHARYNGITIS 3 0.0000
157 HYPERSENSITIVITY 3 0.0000
158 DEEP VEIN THROMBOSIS 1 0.0000
159 HYPOTENSION 3 0.0000
160 PAIN 9 0.0000
161 VISION BLURRED 2 0.0000
162 SLEEP DISORDER 1 0.0000
163 THERAPY INTERRUPTED 1 0.0000
164 SKIN BURNING SENSATION 1 0.0000
165 OVERDOSE 3 0.0000
166 UNDERDOSE 1 0.0000
167 DYSGEUSIA 1 0.0000
168 HOT FLUSH 1 0.0000
169 UNEVALUABLE EVENT 1 0.0000
170 PERIPHERAL SWELLING 2 0.0000
171 DECREASED APPETITE 3 0.0000
172 ARTHRITIS 1 0.0000
173 PARAESTHESIA 2 0.0000
174 INJECTION SITE BRUISING 1 0.0000
175 CONFUSIONAL STATE 2 0.0000
176 NAUSEA 9 0.0000
177 INSOMNIA 3 0.0000
178 TACHYCARDIA 1 0.0000
179 BREAST CANCER 1 0.0000
180 ANXIETY 3 0.0000
181 PAIN IN EXTREMITY 3 0.0000
182 DYSPEPSIA 1 0.0000
183 HEART RATE INCREASED 1 0.0000
184 SYNCOPE 1 0.0000
185 FLUSHING 1 0.0000
186 SINUSITIS 1 0.0000
187 ABDOMINAL PAIN UPPER 2 0.0000
188 PLATELET COUNT DECREASED 1 0.0000
189 RASH 4 0.0000
190 FATIGUE 7 0.0000
191 INFLUENZA 1 0.0000
192 THROMBOCYTOPENIA 1 0.0000
193 WEIGHT INCREASED 2 0.0000
194 RHEUMATOID ARTHRITIS 1 0.0000
195 SEIZURE 1 0.0000
196 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
197 BACK PAIN 2 0.0000
198 ABDOMINAL PAIN 2 0.0000
199 EMOTIONAL DISTRESS 1 0.0000
200 DRY SKIN 1 0.0000
201 INFECTION 1 0.0000
202 PRODUCT DOSE OMISSION ISSUE 2 0.0000
203 DRUG INEFFECTIVE 8 0.0000
204 TREMOR 1 0.0000
205 ABDOMINAL DISCOMFORT 1 0.0000
206 OFF LABEL USE 5 0.0000
207 MUSCLE SPASMS 1 0.0000
208 PRODUCT USE ISSUE 1 0.0000
209 SOMNOLENCE 1 0.0000
210 INCORRECT DOSE ADMINISTERED 1 0.0000
211 FEELING ABNORMAL 1 0.0000
212 INJECTION SITE PAIN 1 0.0000
213 DIARRHOEA 2 0.0000
214 FALL 1 0.0000
215 PYREXIA 1 0.0000